{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:22:13Z","timestamp":1790670133044,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"vor","delay-in-days":1671,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["slas-discovery.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Discovery"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1177\/2472555217716056","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T12:59:30Z","timestamp":1498222770000},"page":"974-984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["High-Throughput Phenotypic Screening of Kinase Inhibitors to Identify Drug Targets for Polycystic Kidney Disease"],"prefix":"10.1016","volume":"22","author":[{"given":"Tijmen H.","family":"Booij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester","family":"Bange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter N.","family":"Leonhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"Fokkelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Kunnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes G.","family":"Dauwerse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"van de Water","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard J.P.","family":"van Westen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorien J.M.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo S.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1177\/2472555217716056_bib1","doi-asserted-by":"crossref","unstructured":"Willey, C. J., Blais, J. D., Hall, A. K., et al. Prevalence of Autosomal Dominant Polycystic Kidney Disease in the European Union. Nephrol. Dial. Transplant. 2016. DOI: https:\/\/doi.org\/10.1093\/ndt\/gfw240.","DOI":"10.1093\/ndt\/gfw240"},{"issue":"9569","key":"10.1177\/2472555217716056_bib2","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal Dominant Polycystic Kidney Disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"issue":"7","key":"10.1177\/2472555217716056_bib3","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ncb3363","article-title":"The Polycystin Complex Mediates Wnt\/Ca(2+) Signalling","volume":"18","author":"Kim","year":"2016","journal-title":"Nat. Cell Biol"},{"issue":"12","key":"10.1177\/2472555217716056_bib4","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1113\/jphysiol.2014.271346","article-title":"Polycystins and Partners: Proposed Role in Mechanosensitivity","volume":"592","author":"Retailleau","year":"2014","journal-title":"J. Physiol"},{"issue":"3","key":"10.1177\/2472555217716056_bib5","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/ndt\/gfs524","article-title":"The Ciliary Flow Sensor and Polycystic Kidney Disease","volume":"28","author":"Kotsis","year":"2013","journal-title":"Nephrol. Dial. Transplant"},{"issue":"12","key":"10.1177\/2472555217716056_bib6","doi-asserted-by":"crossref","first-page":"6397","DOI":"10.1073\/pnas.94.12.6397","article-title":"Polycystin: In Vitro Synthesis, In Vivo Tissue Expression, and Subcellular Localization Identifies a Large Membrane-Associated Protein","volume":"94","author":"Ibraghimov-Beskrovnaya","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"4","key":"10.1177\/2472555217716056_bib7","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ki.2015.207","article-title":"A Polycystin-Centric View of Cyst Formation and Disease: The Polycystins Revisited","volume":"88","author":"Ong","year":"2015","journal-title":"Kidney Int"},{"issue":"1","key":"10.1177\/2472555217716056_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1681\/ASN.2013040398","article-title":"Strategies Targeting cAMP Signaling in the Treatment of Polycystic Kidney Disease","volume":"25","author":"Torres","year":"2014","journal-title":"J. Am. Soc. Nephrol"},{"issue":"15","key":"10.1177\/2472555217716056_bib9","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s40265-015-0475-x","article-title":"Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease","volume":"75","author":"Blair","year":"2015","journal-title":"Drugs"},{"issue":"10","key":"10.1177\/2472555217716056_bib10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrm2236","article-title":"The Third Dimension Bridges the Gap between Cell Culture and Live Tissue","volume":"8","author":"Pampaloni","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol"},{"issue":"9","key":"10.1177\/2472555217716056_bib11","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nrc1695","article-title":"Modelling Glandular Epithelial Cancers in Three-Dimensional Cultures","volume":"5","author":"Debnath","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1177\/2472555217716056_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ymthe.2003.11.021","article-title":"Lentiviral Vectors Efficiently Transduce Quiescent Mature 3T3-L1 Adipocytes","volume":"9","author":"Carlotti","year":"2004","journal-title":"Mol. Ther"},{"issue":"6","key":"10.1177\/2472555217716056_bib13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nbt.2908","article-title":"Dimeric CRISPR RNA-Guided FokI Nucleases for Highly Specific Genome Editing","volume":"32","author":"Tsai","year":"2014","journal-title":"Nat. Biotechnol"},{"issue":"10","key":"10.1177\/2472555217716056_bib14","doi-asserted-by":"crossref","first-page":"e109688","DOI":"10.1371\/journal.pone.0109688","article-title":"Ultra High Content Image Analysis and Phenotype Profiling of 3D Cultured Micro-Tissues","volume":"9","author":"Di","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1177\/2472555217716056_bib15","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1177\/1087057116657269","article-title":"Development of a 3D Tissue Culture-Based High-Content Screening Platform That Uses Phenotypic Profiling to Discriminate Selective Inhibitors of Receptor Tyrosine Kinases","volume":"21","author":"Booij","year":"2016","journal-title":"J. Biomol. Screen"},{"issue":"3","key":"10.1177\/2472555217716056_bib16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"The Toxicity of Poisons Applied Jointly","volume":"26","author":"Bliss","year":"1939","journal-title":"Ann. Appl. Biol"},{"key":"10.1177\/2472555217716056_bib17","series-title":"Assay Guidance Manual [Internet]","article-title":"HTS Assay Validation","author":"Iversen","year":"2012"},{"issue":"1\u20132","key":"10.1177\/2472555217716056_bib18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1432-1033.1997.t01-2-00527.x","article-title":"Biochemical and Cellular Effects of Roscovitine, a Potent and Selective Inhibitor of the Cyclin-Dependent Kinases cdc2, cdk2 and cdk5","volume":"243","author":"Meijer","year":"1997","journal-title":"Eur. J. Biochem"},{"issue":"7","key":"10.1177\/2472555217716056_bib19","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1158\/1535-7163.MCT-08-0017","article-title":"Identification and Characterization of NVP-BEZ235, a New Orally Available Dual Phosphatidylinositol 3-Kinase\/Mammalian Target of Rapamycin Inhibitor with Potent In Vivo Antitumor Activity","volume":"7","author":"Maira","year":"2008","journal-title":"Mol. Cancer Ther"},{"issue":"6","key":"10.1177\/2472555217716056_bib20","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nsmb.2076","article-title":"A Cell-Based Screen Identifies ATR Inhibitors with Synthetic Lethal Properties for Cancer-Associated Mutations","volume":"18","author":"Toledo","year":"2011","journal-title":"Nat. Struct. Mol. Biol"},{"issue":"19","key":"10.1177\/2472555217716056_bib21","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF\/MEK\/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Cancer Res"},{"issue":"1","key":"10.1177\/2472555217716056_bib22","doi-asserted-by":"crossref","first-page":"e87660","DOI":"10.1371\/journal.pone.0087660","article-title":"Activation of the PI3K\/mTOR Pathway Is Involved in Cystic Proliferation of Cholangiocytes of the PCK Rat","volume":"9","author":"Ren","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1177\/2472555217716056_bib23","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1159\/000330080","article-title":"Polycystin-1, 2, and STIM1 Interact with IP(3)R to Modulate ER Ca Release through the PI3K\/Akt Pathway","volume":"27","author":"Santoso","year":"2011","journal-title":"Cell. Physiol. Biochem"},{"issue":"4","key":"10.1177\/2472555217716056_bib24","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1681\/ASN.2014100967","article-title":"Phosphoinositide 3-Kinase-C2alpha Regulates Polycystin-2 Ciliary Entry and Protects against Kidney Cyst Formation","volume":"27","author":"Franco","year":"2016","journal-title":"J. Am. Soc. Nephrol"},{"key":"10.1177\/2472555217716056_bib25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1476-4598-12-46","article-title":"Cell Cycle-Dependent Activity of the Novel Dual PI3K-MTORC1\/2 Inhibitor NVP-BGT226 in Acute Leukemia","volume":"12","author":"Kampa-Schittenhelm","year":"2013","journal-title":"Mol. Cancer"},{"issue":"19","key":"10.1177\/2472555217716056_bib26","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.1021\/jm101144f","article-title":"Discovery of 1-(4-(4-Propionylpiperazin-1-yl)-3-(Trifluoromethyl)Phenyl)-9-(Quinolin-3-yl)Benz o[h][1,6]Naphthyridin-2(1H)- One as a Highly Potent, Selective Mammalian Target of Rapamycin (mTOR) Inhibitor for the Treatment of Cancer","volume":"53","author":"Liu","year":"2010","journal-title":"J. Med. Chem"},{"issue":"12","key":"10.1177\/2472555217716056_bib27","doi-asserted-by":"crossref","first-page":"8023","DOI":"10.1074\/jbc.M900301200","article-title":"An ATP-Competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-Resistant Functions of mTORC1","volume":"284","author":"Thoreen","year":"2009","journal-title":"J. Biol. Chem"},{"issue":"10","key":"10.1177\/2472555217716056_bib28","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1021\/ml200156t","article-title":"Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer","volume":"2","author":"Burger","year":"2011","journal-title":"ACS Med. Chem. Lett"},{"issue":"9","key":"10.1177\/2472555217716056_bib29","doi-asserted-by":"crossref","first-page":"e0133610","DOI":"10.1371\/journal.pone.0133610","article-title":"Evaluation of In Vitro Activity of the Class I PI3K Inhibitor Buparlisib (BKM120) in Pediatric Bone and Soft Tissue Sarcomas","volume":"10","author":"Anderson","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1177\/2472555217716056_bib30","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.2011040340","article-title":"Dose-Dependent Effects of Sirolimus on mTOR Signaling and Polycystic Kidney Disease","volume":"23","author":"Novalic","year":"2012","journal-title":"J. Am. Soc. Nephrol"},{"issue":"14","key":"10.1177\/2472555217716056_bib31","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR Pathway Is Regulated by Polycystin-1, and Its Inhibition Reverses Renal Cystogenesis in Polycystic Kidney Disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1177\/2472555217716056_bib32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13073-015-0215-6","article-title":"Pharmacological Inhibition of DNA-PK Stimulates Cas9-Mediated Genome Editing","volume":"7","author":"Robert","year":"2015","journal-title":"Genome Med."},{"issue":"2","key":"10.1177\/2472555217716056_bib33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.ki.5002229","article-title":"Hyperproliferation of PKD1 Cystic Cells Is Induced by Insulin-Like Growth Factor-1 Activation of the Ras\/Raf Signalling System","volume":"72","author":"Parker","year":"2007","journal-title":"Kidney Int"},{"issue":"6","key":"10.1177\/2472555217716056_bib34","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.4155\/fmc.09.89","article-title":"Discovery of OSI-906: A Selective and Orally Efficacious Dual Inhibitor of the IGF-1 Receptor and Insulin Receptor","volume":"1","author":"Mulvihill","year":"2009","journal-title":"Future Med. Chem"},{"issue":"6","key":"10.1177\/2472555217716056_bib35","doi-asserted-by":"crossref","first-page":"e0131043","DOI":"10.1371\/journal.pone.0131043","article-title":"TNFalpha Signaling Regulates Cystic Epithelial Cell Proliferation through Akt\/mTOR and ERK\/MAPK\/Cdk2 Mediated Id2 Signaling","volume":"10","author":"Zhou","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1177\/2472555217716056_bib36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000446879","article-title":"Spleen Tyrosine Kinase: A Crucial Player and Potential Therapeutic Target in Renal Disease","volume":"133","author":"Ma","year":"2016","journal-title":"Nephron"},{"issue":"5","key":"10.1177\/2472555217716056_bib37","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1046\/j.1523-1755.2003.00256.x","article-title":"EGF Receptor Tyrosine Kinase Inhibition Attenuates the Development of PKD in Han:SPRD Rats","volume":"64","author":"Torres","year":"2003","journal-title":"Kidney Int"},{"issue":"7","key":"10.1177\/2472555217716056_bib38","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bbadis.2006.04.006","article-title":"Inhibition of HER-2(neu\/ErbB2) Restores Normal Function and Structure to Polycystic Kidney Disease (PKD) Epithelia","volume":"1762","author":"Wilson","year":"2006","journal-title":"Biochim. Biophys. Acta"}],"container-title":["SLAS Discovery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2472555217716056","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2472555217716056","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555222070290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555222070290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2472555217716056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T11:46:53Z","timestamp":1762861613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2472555222070290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S2472555222070290"],"URL":"https:\/\/doi.org\/10.1177\/2472555217716056","relation":{},"ISSN":["2472-5552"],"issn-type":[{"value":"2472-5552","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-Throughput Phenotypic Screening of Kinase Inhibitors to Identify Drug Targets for Polycystic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"SLAS Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1177\/2472555217716056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 Society for Laboratory Automation and Screening. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}